Try our beta test site
1 study found for:    NCT01097096
Show Display Options
Rank Status Study
1 Completed Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Condition: Alzheimer's Disease
Intervention: Biological: CAD106

Study has passed its completion date and status has not been verified in more than two years.